ArticleInternational journal of molecular sciences2026
Theranostic Nanoparticles Based on a Silicon Dioxide Core, a Mercapto Spacer, a Cardioprotector, and a Fluorescent Dye.
Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
A method for synthesizing theranostic nanoparticles (NPs) based on a silica core, a mercapto spacer, a cardioprotector, and a fluorescent dye has been developed. The total amount of grafted mercapto groups was 0.079 mmol/g. The amount of accessible mercapto groups on the surface of the synthesized particles, calculated using the Kunkel, Buckley, and Gorin method, was 0.025 mmol/g. A total of 0.031 mmol/g of adenosine and 0.0087 mmol/g of indocyanine green are grafted onto the mercapto spacer. Both substances are presumably attached via hydrogen bonding to the modified silica nanoparticle in a ratio of 60/40% for adenosine and indocyanine green, respectively. The resulting nanoparticles exhibit no hemolytic activity. Intensive adenosine release occurs within 90 min and continues for up to 24 h. Based on biodistribution, significant accumulation of the nanoparticles occurs in the liver.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.